Skip to content
Dr. Grey AI

Supplement

Akkermansia muciniphila

Akkermansia muciniphila is a bacterium that lives in the gut's mucus lining, where it helps support the gut barrier and metabolism. In a trial of 90 people, a pasteurized form improved insulin sensitivity by about 29% over placebo, and a smaller study found lower insulin levels in metabolic syndrome. The evidence is limited, though: studies were small, and blood sugar and weight benefits appeared only in some people.

Best evidence
Grade C
Conditions studied
6
Outcomes
6
Graded outcomes
0060

Evidence by condition

  • Strong
  • Moderate
  • Limited
  • Very limited

6 conditions

Insulin Resistance

Insulin Resistance: outcomes studied for Akkermansia muciniphila
GradeOutcomeEffectSizeStudiesPeopleStudies list
Insulin Sensitivity

+28.6% improvement in insulin sensitivity vs placebo (pasteurized form)

Improves (the measure goes up)Moderate effect90 people
Metabolic Syndrome: outcomes studied for Akkermansia muciniphila
GradeOutcomeEffectSizeStudiesPeopleStudies list
Insulinemia

-34% reduction in plasma insulin levels

Improves (the measure goes down)Moderate effect32 people

Cholesterol

  • Total Cholesterol: improves
Cholesterol: outcomes studied for Akkermansia muciniphila
GradeOutcomeEffectSizeStudiesPeopleStudies list
Total Cholesterol

-8.7% reduction in total cholesterol

Improves (the measure goes down)Small effect32 people

Type 2 Diabetes

  • HbA1c: improves
Type 2 Diabetes: outcomes studied for Akkermansia muciniphila
GradeOutcomeEffectSizeStudiesPeopleStudies list
HbA1c

Significant reduction in HbA1c (only in those with low baseline A. muciniphila)

Improves (the measure goes down)Moderate effect58 people

Obesity

  • Body Weight: improves
Obesity: outcomes studied for Akkermansia muciniphila
GradeOutcomeEffectSizeStudiesPeopleStudies list
Body Weight

Significant reduction in body weight and fat mass (responders only)

Improves (the measure goes down)Small effect58 people

Liver Health

  • Liver Function Markers: improves
Liver Health: outcomes studied for Akkermansia muciniphila
GradeOutcomeEffectSizeStudiesPeopleStudies list
Liver Function Markers

Reduced markers of liver dysfunction and inflammation

Improves (the measure goes down)Small effect32 people

Key findings

  • Insulin SensitivityImproves (the measure goes up)
  • InsulinemiaMetabolic SyndromeImproves (the measure goes down)
  • Total CholesterolImproves (the measure goes down)

Shop Akkermansia muciniphila

Third-party tested Akkermansia muciniphila products. The evidence above is limited, so read it before you buy.

  • Grade C

Links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Fullscript asks for a free account before it shows its catalog and prices. Full disclosure

Studies cited

3 studies from PubMed

  1. Akkermansia muciniphila supplementation in patients with overweight/obese type 2 diabetes: Efficacy depends on its baseline levels in the gutCell Metab, 2025 · PMID 39879980
  2. A comprehensive systematic review of the effectiveness of Akkermansia muciniphila for the management of obesity and associated metabolic disordersArch Med Res, 2021 · PMID 33449810
  3. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory studyNat Med, 2019 · PMID 31263284